Package Leaflet: Information for the Patient
Latanoprost Yonsung 50 micrograms/ml eye drops, solution in single-dose container
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
Latanoprost Yonsung belongs to a group of medications known as prostaglandin analogs. It works by increasing the natural outflow of fluid from the inside of the eye into the bloodstream.
Latanoprost Yonsung is used to treat diseases known as open-angle glaucoma and ocular hypertension. Both diseases are related to an increase in pressure inside the eye, which can affect vision.
Do not use Latanoprost Yonsung
If you are allergic (hypersensitive) to latanoprost or any of the other components of this medication (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to use latanoprost if you think any of the following situations apply to you:
Children
The use of this medication has not been studied in children (under 18 years of age).
Other medications and Latanoprost Yonsung
Latanoprost may interact with other medications. Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Pregnancy and breastfeeding
Do not use Latanoprost Yonsungif you are pregnant or breastfeeding, unless your doctor considers it necessary.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
When using latanoprost, blurred vision may occur for a short period. If this happens, do not driveor use tools or machines until your vision is clear again.
Latanoprost Yonsung contains phosphates
This medication contains 6.3 mg/ml of phosphates, which is equivalent to 0.24 mg/drop.
If you have severe damage to the clear layer on the front of the eye (the cornea), treatment with phosphates, in very rare cases, may cause cloudy patches on the cornea due to calcium deposits produced during treatment.
Contact lens users
If you use contact lenses, you must remove them before using latanoprost. After applying latanoprost, wait 15 minutes before putting your contact lenses back in.
Instructions for use
Each carton contains 3 or 9 sachets. Open only one sachet at a time. Use all the single-dose containers before opening the next sachet.
Separate the single-dose container from the strip before use.
If you use Latanoprost Yonsung with other eye drops
Wait at least 5 minutes between applying latanoprost and administering other eye drops.
If you use more Latanoprost Yonsung than you should
If you have applied more drops in the eye than you should, you may feel mild irritation in the eye, and your eyes may become red and tearful. This situation should resolve on its own, but if you are concerned, contact your doctor.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service immediately, phone 91 562 04 20, indicating the medication and the amount used.
If you forget to use Latanoprost Yonsung
Continue with the next scheduled dose as usual. Do not apply an extra drop in the eye to make up for the missed dose. If you have doubts, consult your doctor or pharmacist.
If you stop using Latanoprost Yonsung
If you want to stop using latanoprost, you must consult your doctor.
If you have any other questions about using this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can cause side effects, although not everyone will experience them.
The following adverse reactions are known with the use of latanoprost:
Very common side effects(may affect more than 1 in 10 patients):
Common side effects(may affect up to 1 in 10 patients):
Uncommon side effects(may affect up to 1 in 100 patients):
Rare side effects(may affect up to 1 in 1,000 patients):
Very rare side effects(may affect up to 1 in 10,000 patients):
Very rare cases of corneal calcification associated with the use of eye drops containing phosphates have been reported in some patients with significantly damaged corneas.
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Toxicology Surveillance System: https//:notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging, carton, and single-dose container. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Keep the sachet in the carton once opened to protect it from light.
After opening the sachet: use the single-dose containers within 20 days.
After opening the single-dose container: use immediately and discard the single-dose container after use.
Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in your pharmacy. If you have doubts, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
Composition of Latanoprost Yonsung
Appearance of the product and pack contents
Latanoprost Yonsung eye drops are a colorless or slightly yellowish solution in single-dose containers.
The single-dose containers are packaged in a sachet with 10 units (two strips of 5 single-dose containers), each single-dose container contains 0.2 ml of eye drops in solution.
The cartons contain 30 single-dose containers (3 sachets with 10 single-dose containers).
The cartons contain 90 single-dose containers (9 sachets with 10 single-dose containers).
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
YONSUNG GmbH
Zeppelinstrasse 14
78244 Gottmadingen
Germany
Local representative
XENTENEL PHARMA EUROPE, S.L.
Vallsolana Garden Business Park
Camí de Can Camps, 17-19 – Kibo Building
08174 Sant Cugat del Vallès
Spain
93 836 4600
drug-safety@xentenel.es
Date of the last revision of this package leaflet: May 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)